Sign In
Buy DARE
$2.07
+0.0200 (+0.98%)
At Close: Jun 23, 2026
A Nano Drug Delivery IPO from Cerulean Pharma
01:30pm, Wednesday, 12'th Mar 2014
In a previous article, we discussed Bind Therapeutics (NASDAQ:BIND), a company developing a nano-drug delivery technology for Docetaxel, one of the most commonly used cancer chemotherapy drugs app
